Clinical Journal of the American Society of Nephrology

Article	Citations
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis	267
Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19	158
Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN)	139
Drug-Induced Acute Kidney Injury	119
Classification of Uremic Toxins and Their Role in Kidney Failure	105
Social Determinants of Health and Race Disparities in Kidney Transplant	103
Long-Term Outcomes in IgA Nephropathy	98
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2	97
Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2	92
Risk Factors for CKD Progression	83
Clinical Implications of an Acute Dip in eGFR after SGLT2 Inhibitor Initiation	82
Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies	80
Fatigue in CKD	76
Guidelines for Genetic Testing and Management of Alport Syndrome	69
Long-Term Immunosuppression Management	68
Long-Term Infectious Complications of Kidney Transplantation	65
Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy	63
Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury	60
Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19	59
The Pathophysiology of Sepsis-Associated AKI	58
Deep Learning Model for Real-Time Prediction of Intradialytic Hypotension	54
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1	54
Outcomes of COVID-19 in CKD Patients	52
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD	52
Effect of Aerobic Exercise on Dialysis-Related Symptoms in Individuals Undergoing Maintenance Hemodialysis	51

Nephrologist Follow-Up versus Usual Care after an Acute Kidney Injury Hospitalization (FUSION): A Randomized Controlled Trial	50
COVID-19–Associated Mortality among Kidney Transplant Recipients and Candidates in the United States	49
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months	46
Recurrence of IgA Nephropathy after Kidney Transplantation in Adults	45
Management of Heart Failure Patient with CKD	45
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease	44
Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients	44
Overweight and Obesity and Progression of ADPKD	43
Dietary Potassium Intake and All-Cause Mortality in Adults Treated with Hemodialysis	43
Recovery after Critical Illness and Acute Kidney Injury	41
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria	40
Severity of COVID-19 after Vaccination among Hemodialysis Patients	40
Genetic Basis of Type IV Collagen Disorders of the Kidney	40
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD	39
SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function	39
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome	39
Inherited Kidney Complement Diseases	39
Association of Polypharmacy with Kidney Disease Progression in Adults with CKD	38
Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19	37
De Novo Malignancies after Kidney Transplantation	37
Vaccination and COVID-19 Dynamics in Dialysis Patients	36
Long-Term Care of the Pediatric Kidney Transplant Recipient	35
Managing Patients with Failing Kidney Allograft	35
Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy	35
A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis Facility	34
Postoperative Acute Kidney Injury	34
Recurrent Glomerular Disease after Kidney Transplantation	33
Impact of COVID-19 Pandemic in Children with CKD or Immunosuppression	33
Neural Epidermal Growth Factor–Like 1 Protein–Positive Membranous Nephropathy in Chinese Patients	32
Risk of COVID-19 Disease, Dialysis Unit Attributes, and Infection Control Strategy among London In-Center Hemodialysis Patients	32
Ambulatory Treatments for RAAS Inhibitor–Related Hyperkalemia and the 1-Year Risk of Recurrence	31
The Continuum of Acid Stress	31
Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes	31
The Mobile Health Readiness of People Receiving In-Center Hemodialysis and Home Dialysis	31
Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy	31
Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline	30
Ertugliflozin and Slope of Chronic eGFR	30
Safety and Efficacy of Belimumab in Patients with Lupus Nephritis	30
Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients	30
Reliability and Validity of the Patient Activation Measure in Kidney Disease: Results of Rasch Analysis	30
Identification of Patients with CKD in Medical Databases	30
Acute Kidney Injury in Patients with Liver Disease	29
Digenic Alport Syndrome	29
Kidney-Protective Effects of SGLT2 Inhibitors	29
Association between Postmortem Kidney Biopsy Findings and Acute Kidney Injury from Patients with SARS-CoV-2 (COVID-19)	29
Video-Based Telemedicine for Kidney Disease Care	28
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease	28
Chronic Allograft Injury	28
Association of Depressive Symptoms with Rapid Kidney Function Decline in Adults with Normal Kidney Function	27
Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis	27

Post-Transplant Cardiovascular Disease	27
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease	27
Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide	26
Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019	26
Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum	26
Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety	26
SGLT2 Inhibitors in Diabetic Kidney Disease	26
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease	25
Bone and Mineral Disease in Kidney Transplant Recipients	25
Symptom Burden before and after Dialysis Initiation in Older Patients	25
Preliminary Assessment of Acute Kidney Injury in Critically Ill Children Associated with SARS-CoV-2 Infection	25
Evaluation of PROMIS Preference Scoring System (PROPr) in Patients Undergoing Hemodialysis or Kidney Transplant	24
Metabolite Biomarkers of CKD Progression in Children	24
Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD	24
Assessing Global Kidney Nutrition Care	24
Variation in Peritoneal Dialysis Time on Therapy by Country	24
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease	23
The Effect of Gender-Affirming Hormone Therapy on Measures of Kidney Function	23
Mass Disasters and Burnout in Nephrology Personnel	23
Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation	23
Prevalence and Risk Factors for Kidney Disease and Elevated BP in 2-Year-Old Children Born Extremely Premature	23
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood	23
Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort	23
The Kidney in Normal Aging	23
Sex Disparity in Deceased-Donor Kidney Transplant Access by Cause of Kidney Disease	23
Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis	23
Depression Screening Tools for Patients with Kidney Failure	23
Provider Perception of Frailty Is Associated with Dialysis Decision Making in Patients with Advanced CKD	23
Comparative Effects of Etelcalcetide and Maxacalcitol on Serum Calcification Propensity in Secondary Hyperparathyroidism	22
Performance of ChatGPT on Nephrology Test Questions	22
NAT8 Variants, N-Acetylated Amino Acids, and Progression of CKD	22
Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis	22
Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness	22
Overview of Diagnostic Criteria and Epidemiology of Acute Kidney Injury and Acute Kidney Disease in the Critically Ill Patient	22
Social Determinants of Kidney Health	22
Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis	22
Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination	22
Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD	22
Associations between Deprivation, Geographic Location, and Access to Pediatric Kidney Care in the United Kingdom	22
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy	22
Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis	22
Low-Flow Acute Kidney Injury	22
Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States	22
Use of Race in Kidney Research and Medicine	21
Urinary Cell mRNA Profiles Predictive of Human Kidney Allograft Status	21
The Pathogenesis of Race and Ethnic Disparities	21
Metabolites Associated with Coffee Consumption and Incident Chronic Kidney Disease	20
Strategies to Prevent Acute Kidney Injury after Pediatric Cardiac Surgery	20
In-Hospital and 1-Year Mortality Trends in a National Cohort of US Veterans with Acute Kidney Injury	20
Expression of CD147 and Cyclophilin A in Kidneys of Patients with COVID-19	20
Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor–Associated Adverse Events	20
Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project	20
Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression	20
Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease	19
Severe Acute Kidney Injury and Mortality in Extremely Low Gestational Age Neonates	19
Electrolyte and Acid-Base Disorders Associated with Cancer Immunotherapy	19
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients	19
Association of Phosphate-Containing versus Phosphate-Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy	19
Association of HLA Mismatches and Histology Suggestive of Antibody-Mediated Injury in the Absence of Donor-Specific Anti-HLA Antibodies	18
Nocturnal Systolic Hypertension and Adverse Prognosis in Patients with CKD	18
Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance	18
Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients	18
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis	18
C3 Glomerulopathy and Related Disorders in Children	18
Collectin11 and Complement Activation in IgA Nephropathy	18
Chronic Kidney Disease and Severe Mental Illness	18
SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis	18
Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis	18
Soluble Klotho and Incident Hypertension	18
Kidney Disease Symptoms before and after Kidney Transplantation	18
Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease	18
Waiting Time for Second Kidney Transplantation and Mortality	18
Acute Kidney Injury in Critically Ill Patients with Cancer	18
Long-Term Effect of Physical Exercise on the Risk for Hospitalization and Death in Dialysis Patients	18
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes	17
NephroTalk Multimodal Conservative Care Curriculum for Nephrology Fellows	17
When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis	17
Age and the Course of GFR in Persons Aged 70 and Above	17
Predictive Approaches for Acute Dialysis Requirement and Death in COVID-19	17
The Intensivist's Perspective of Shock, Volume Management, and Hemodynamic Monitoring	17

Radiographic Contrast Media and the Kidney	17
The Seen and the Unseen: Race and Social Inequities Affecting Kidney Care	17
COVID-19 among Adults Receiving Home versus In-Center Dialysis	17
Transplant Clinician Opinions on Use of Race in the Estimation of Glomerular Filtration Rate	17
Intravenous Albumin for Mitigating Hypotension and Augmenting Ultrafiltration during Kidney Replacement Therapy	17
Food Insecurity and Kidney Disease	17
Beyond the Biopsy: Monitoring Immune Status in Kidney Recipients	16
Metabolomic Markers of Ultra-Processed Food and Incident CKD	16
Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients	16
Digital Applications Targeting Medication Safety in Ambulatory High-Risk CKD Patients	16
Effectiveness of Three Doses of mRNA COVID-19 Vaccines in the Hemodialysis Population during the Omicron Period	16
Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD	16
Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse	16
Quality of Life before and after the Start of Dialysis in Older Patients	16
Effect of the Refitted Race-Free eGFR Formula on the CKD Prevalence and Mortality in the Danish Population	16
Mass Transport in High-Flux Hemodialysis	16
Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury	16
Acid-Base Disorders in the Critically Ill Patient	16
Association of Mitochondrial DNA Copy Number with Risk of Progression of Kidney Disease	16
Lifesaving Care for Patients with Kidney Failure during the War in Ukraine 2022	15
Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2– Recovered Dialysis Patients	15
Implementation of a Staff-Assisted Peritoneal Dialysis Program in the United States	15
Kidney Disease Prevalence in Transgender Individuals	15
The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function	15
Heart Failure Hospitalization Risk associated with Iron Status in Veterans with CKD	15
Effects of Bardoxolone Methyl in Alport Syndrome	15
Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease	15
Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease	15
Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019	15
Health-Related Quality-of-Life Trajectories over Time in Older Men and Women with Advanced Chronic Kidney Disease	14
Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease	14
Extracorporeal Treatment for Methotrexate Poisoning	14
Transforming the Care of Patients with Diabetic Kidney Disease	14
Functional Reserve of the Kidney	14
Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems	14
Mortality and Access to Kidney Transplantation in Patients with Sickle Cell Disease–Associated Kidney Failure	14
Can Novel Potassium Binders Liberate People with Chronic Kidney Disease from the Low-Potassium Diet?	14
Continuous KRT	14
Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients	14
Poly-IgA Complexes and Disease Severity in IgA Nephropathy	14
Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese	14
GLP-1 Receptor Agonists in Diabetic Kidney Disease	14
Uromodulin, Salt, and 24-Hour Blood Pressure in the General Population	14
Kidney Effects of Empagliflozin in People with Type 1 Diabetes	14
Associations of COVID-19 Outcomes with Dialysis Modalities and Settings	13
Endothelin Receptor Antagonists for Kidney Protection	13
The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States	13
Diagnostic Performance of Fractional Excretion of Sodium for the Differential Diagnosis of Acute Kidney Injury	13
Post-Transplant Pregnancy and Contraception	13
Targeting Sedentary Behavior in CKD	13
Extracellular Vesicles as Theranostic Tools in Kidney Disease	13
Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis	13
Net Endogenous Acid Excretion and Kidney Allograft Outcomes	13
Patient and Caregiver Experiences and Attitudes about Their Involvement in Research in Chronic Kidney Disease	13
Change in Physical Activity and Function in Patients with Baseline Advanced Nondialysis CKD	13
Kidney Failure Risk Equation and Cost of Care in Patients with Chronic Kidney Disease	13
Pharmacokinetic Properties of Dapagliflozin in Hemodialysis and Peritoneal Dialysis Patients	12
Vaccines and Disease Relapses in Children with Nephrotic Syndrome	12
Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies	12
Fixed-Dose Combination Therapy for the Prevention of Cardiovascular Diseases in CKD	12
Sepsis Management for the Nephrologist	12
Racial Disparities in Pediatric Kidney Transplantation under the New Kidney Allocation System in the United States	12
Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome	12
Point-of-Care Ultrasound Training during Nephrology Fellowship	12
Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS	12
Pharmacokinetics of Remdesivir and GS-441524 during PIRRT and Seraph 100 Therapy	12
Discrepancies between Cystatin C–Based and Creatinine-Based eGFR	12
Effect of Hemodiafiltration on the Progression of Neuropathy with Kidney Failure	12
The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation	12
Reimagining Nephrology Fellowship Education to Meet the Future Needs of Nephrology	12
Latency, Anti-Bacterial Resistance Pattern, and Bacterial Infection–Related Glomerulonephritis	12
Toxic Occupational Exposures and Membranous Nephropathy	11
Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection	11
Five-Year Symptom Trajectories in Nondialysis-Dependent CKD Patients	11
Cognitive Dysfunction and Gait Abnormalities in CKD	11
Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients	11
Nephronophthisis in Young Adults Phenocopying Thrombotic Microangiopathy and Severe Nephrosclerosis	11
Prediction of Incident Atrial Fibrillation in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study	11
Integrating Patient Perspectives into Medical Device Regulatory Decision Making to Advance Innovation in Kidney Disease	11
The Effects of Oral Energy-Dense Supplements on Nutritional Status in Nondiabetic Maintenance Hemodialysis Patients	11
Acute Kidney Injury among Black Patients with Sickle Cell Trait and Sickle Cell Disease	11
Prasugrel and Ticagrelor in Patients with Drug-Eluting Stents and Kidney Failure	11
Urine Output Monitoring for the Diagnosis of Early-Onset Acute Kidney Injury in Very Preterm Infants	11
Source of Post-Transplant Care and Mortality among Kidney Transplant Recipients Dually Enrolled in VA and Medicare	11
The Association of Time to Organ Procurement on Short- and Long-Term Outcomes in Kidney Transplantation	11
Treatment Decision Making for Older Kidney Patients during COVID-19	11
Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children	11
Barriers and Solutions to Kidney Transplantation for the Undocumented Latinx Community with Kidney Failure	11
Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study	11
Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Kidney Failure Patients Treated with Dialysis: A Systematic Review and Meta-Analysis	11
Implications of Accumulated Cold Time for US Kidney Transplantation Offer Acceptance	10
Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development	10
Automatic Evaluation of Histological Prognostic Factors Using Two Consecutive Convolutional Neural Networks on Kidney Samples	10
Immunosuppression versus Supportive Care on Kidney Outcomes in IgA Nephropathy in the Real-World Setting	10
Balancing the Needs of Acute and Maintenance Dialysis Patients during the COVID-19 Pandemic	10